A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage

Nimodipine is the only drug approved for use by the Food and Drug Administration for improving outcome after aneurysmal subarachnoid hemorrhage (SAH). It has less than optimal efficacy, causes dose-limiting hypotension in a substantial proportion of patients, and is administered enterally 6 times da...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurotherapeutics
Main Authors: Hänggi, Daniel, Etminan, Nima, Steiger, Hans Jakob, Johnson, Mark, Peet, M. Melissa, Tice, Tom, Burton, Kevin, Hudson, Bruce, Turner, Michele, Stella, Angela, Heshmati, Parissa, Davis, Cara, Faleck, Herbert J., Macdonald, R. Loch
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4824023/
https://ncbi.nlm.nih.gov/pubmed/26935204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-016-0424-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados